急性环境下食管癌与胃癌微创手术的安全性与可行性:全国队列研究
该全国队列研究基于荷兰上消化道癌症审计数据库,纳入2011至2017年因原发性食管癌或胃癌行急性手术的患者,评估微创手术的转化率、术后并发症、再干预、死亡率、住院时间及肿瘤学结局。结果显示急性环境下胃癌微创手术安全可行,短期临床与肿瘤学结局至少与开腹手术相当,但转化率较高,食管癌急性微创手术例数极少未作比较。
要点
- 急性食管胃结合部肿瘤手术仅占全部手术的2%(190/8861)。
- 急性胃癌微创手术转化率为23%(9例),术后并发症36% vs 开腹51%。
- 胃癌微创手术的根治性切除率87% vs 66%,中位淋巴结检出数21 vs 16。
核心结论
- 胃癌微创手术在急性环境下安全可行,术后临床与短期肿瘤学结局至少与开腹手术相当,但转化率较高。
- 急性食管癌微创手术例数极少,未进行微创与开腹的比较。
研究设计与样本
- 基于荷兰上消化道癌症审计(DUCA)全国数据库的队列研究,纳入2011至2017年因原发性食管癌或胃癌行急性手术的患者。
主要发现
- 2011至2017年荷兰急性环境下食管胃癌手术占2%(190/8861)。
- 急性食管癌切除14例,其中微创7例、开腹7例,未作比较。
- 急性胃癌切除122例,其中微创39例、开腹83例。
- 微创胃癌手术转化9例(23%)。
- 微创与开腹胃癌手术比较:术后并发症36% vs 51%,中位住院9天(IQR 7-16)vs 11天(IQR 7-17),再入院8% vs 11%,根治性切除率87% vs 66%,中位淋巴结检出数21(IQR 15-32)vs 16(IQR 11-24)。
临床怎么用
- 急性胃癌手术可考虑微创入路,但需告知患者转化风险较高。
- 急性食管癌微创手术证据有限,需个体化决策。
局限性
- 急性食管癌微创与开腹手术例数极少,无法比较。
- 为回顾性 nationwide 队列研究,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive esophagectomy and gastrectomy are increasingly performed and might be superior to their open equivalents in an elective setting. The aim of this study was to evaluate whether minimally invasive approaches can be safely applied in the acute setting as well. METHODS: All patients who underwent an acute surgical intervention for primary esophageal or gastric cancer between 2011 and 2017 were identified from the nationwide database of the Dutch Upper GI Cancer Audit (DUCA). Conversion rates, postoperative complications, re-interventions, postoperative mortality, hospital stay and oncological outcomes (radical resection rates and median lymph node yield) were evaluated. RESULTS: Between 2011 and 2017, surgery for esophagogastric cancer was performed in an acute setting in 2% (190/8861) in The Netherlands. A total of 14 acute resections for esophageal cancer were performed, which included 7 minimally invasive esophagectomies and 7 open esophagectomies. As these numbers were very low, no comparison between minimally invasive and open esophagectomies was made. A total of 122 acute resections for gastric cancer were performed, which included 39 minimally invasive gastrectomies and 83 open gastrectomies. Conversion occurred in 9 patients (23%). Minimally invasive gastrectomy was at least comparable to open gastrectomy regarding postoperative complications (36% versus 51%), median hospital stay (9 days [IQR: 7-16 days] versus 11 days [IQR: 7-17 days]), readmissions (8% versus 11%) and oncological outcomes (radical resection rate: 87% versus 66%, median lymph node yield: 21 [IQR: 15-32 days] versus 16 [IQR: 11-24 days]). CONCLUSIONS: Minimally invasive surgery for gastric cancer is safe and feasible in the acute setting, with at least comparable postoperative clinical and short-term oncological outcomes compared to open surgery but a relatively high conversion rate.
引用
- Borggreve AS, Kingma BF, Ruurda JP, et al. Safety and feasibility of minimally invasive surgical interventions for esophageal and gastric cancer in the acute setting: a nationwide cohort study. Surg Endosc. 2020. PMID: 32215746. doi:10.1007/s00464-020-07491-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。